ArticleBMC cancer2016
Stage of breast cancer at diagnosis in New Zealand: impacts of socio-demographic factors, breast cancer screening and biology.
Article in BMC cancer, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 54 citations in OpenAlex.
- The benefits and acceptability of virtual reality interventions for women with metastatic breast cancer in their homes; a pilot randomised trial.BMC cancer · 2022Trial
- Intercontinental comparison of women with breast cancer treated by oncologists in Europe, Asia, and Latin America: a retrospective study of 99,571 patients.Journal of cancer research and clinical oncology · 2023Article
- Impact of diabetes on surgery and radiotherapy for breast cancer.Breast cancer research and treatment · 2023Article
- Burden of breast cancer and attributable risk factors in the North Africa and Middle East region, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.Frontiers in oncology · 2023Article
- Characteristics and survival of de novo and recurrent metastatic breast cancer in New Zealand.Breast cancer (Tokyo, Japan) · 2021Article
- Under-ascertainment of breast cancer susceptibility gene carriers in a cohort of New Zealand female breast cancer patients.Breast cancer research and treatment · 2021Article
- Adherence to Adjuvant Tamoxifen in Mexican Young Women with Breast Cancer.Patient preference and adherence · 2021Article
- Young Women With Breast Cancer in Mexico: Results of the Pilot Phase of the Joven & Fuerte Prospective Cohort.JCO global oncology · 2020Article
- Advanced Breast Cancer at Diagnosis: Over One Third Adherent to Screening Recommendations.Women's health reports (New Rochelle, N.Y.) · 2020Article
- Spatial distribution of breast cancer in Sudan 2010-2016.PloS one · 2019Article
- Locally advanced breast cancer in young women in Latin America.Ecancermedicalscience · 2019Review
- Development and validation of a new predictive model for breast cancer survival in New Zealand and comparison to the Nottingham prognostic index.BMC cancer · 2018Article
- Assessment of cancers' diagnostic stage in a Deaf community - survey about 4363 Deaf patients recorded in French units.BMC cancer · 2018Article
- Ethnic disparities in breast cancer survival in New Zealand: which factors contribute?BMC cancer · 2018Article
- Potential factors associated with clinical stage of nasopharyngeal carcinoma at diagnosis: a case-control study.Chinese journal of cancer · 2017Article
- Determinants of stage at diagnosis of breast cancer in Nigerian women: sociodemographic, breast cancer awareness, health care access and clinical factors.Cancer causes & control : CCC · 2017Article
- Urban Rural Differences in Breast Cancer in New Zealand.International journal of environmental research and public health · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundExamination of factors associated with late stage diagnosis of breast cancer is useful to identify areas which are amenable to intervention. This study analyses trends in cancer stage at diagnosis and impact of socio-demographic, cancer biological and screening characteristics on cancer stage in a population-based series of women with invasive breast cancer in New Zealand.
methodsAll women diagnosed with invasive breast cancer between 2000 and 2013 were identified from two regional breast cancer registries. Factors associated with advanced (stages III and IV) and metastatic (stage IV) cancer at diagnosis were analysed in univariate and multivariate models adjusting for covariates.
resultsOf the 12390 women included in this study 2448 (19.7%) were advanced and 575 (4.6%) were metastatic at diagnosis. Māori (OR = 1.86, 1.39-2.49) and Pacific (OR = 2.81, 2.03-3.87) compared with NZ European ethnicity, other urban (OR = 2.00, 1.37-2.92) compared with main urban residency and non-screen (OR = 6.03, 4.41-8.24) compared with screen detection were significantly associated with metastatic cancer at diagnosis in multivariate analysis. A steady increase in the rate of metastatic cancer was seen which has increased from 3.8% during 2000-2003 to 5.0% during 2010-2013 period (p = 0.042).
conclusionsProviding equitable high quality primary care and increasing mammographic screening coverage needs to be looked at as possible avenues to reduce late-stage cancer at diagnosis and to reduce ethnic, socioeconomic and geographical disparities in stage of breast cancer at diagnosis in New Zealand.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.